Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, has announced that the Committee for Medicinal Products for…
Pharmaceuticals, Biotechnology and Life Sciences
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, has announced that the Committee for Medicinal Products for…
Idorsia Ltd has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European…
Orphazyme A/SCompany announcementNo. 07/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 23, 2022 – Orphazyme A/S (ORPHA.CO (DK); ORPH (US))…
MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing,…
dievini Hopp BioTech holding GmbH & Co. KG (dievini), DH-LT-Investments GmbH and Dietmar Hopp, as well as the managing directors…
TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved treatments for thrombotic diseases, has announced it has raised…
Myricx Pharma (‘Myricx’), a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT)…
Collaboration leverages BioNTech’s multi-platform immunotherapy capabilities and Medigene’s T cell receptor (TCR) discovery platform to discover and develop innovative TCR…
Molecule, a biotech IP Web3 marketplace, has announced a tripartite partnership with Apollo Health Ventures, a longevity-focused venture capital fund,…
PrecisionLife Limited has appointed Colin Stubberfield, Ph.D. as SVP Drug Discovery. He will be based at the company’s UK headquarters…